Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danazol in Advanced or Recurrent Endometrial Cancer
NCT00003946Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Aug 1999
- Primary completion
- Jun 2003
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of danazol in endometrial cancer (EC), sponsored by GOG Foundation. Started Aug 1999; status: completed.
02
Drugs
danazol
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00003946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003946.